Research firm Datamonitor says 3PLs have considerable potential to capture market share in the European pharmaceutical industry due to their expertise and easing of strict compliance codes.
The best opportunities for 3PLs will be available to those who can offer global networks to clients who are relocating their manufacturing bases to low-cost countries due to the deregulation of the pharmaceutical market and the strengthening of intellectual property agreements